News
Public · Published
Precigen, Inc. reports results for the quarter ended September 30 - Earnings Summary
Precigen reported adjusted earnings of 8 cents per share for the quarter ended September 30, compared with a loss per share a year earlier. Revenue rose 2,437.6% to $74.15 million, above analysts' $71.56 million expectation, and the company reported net income of $35.77 million.
Published:
Updated:
What happened
Precigen reported adjusted earnings of 8 cents per share for the quarter ended September 30, compared with a loss per share a year earlier. Revenue rose 2,437.6% to $74.15 million, above analysts’ $71.56 million expectation, and the company reported net income of $35.77 million.
Confirmed
Global impact / market context
The return to adjusted profit and revenue above expectations could improve investor confidence in Precigen’s ability to generate income and grow sales. However, the figures alone do not show whether the large year-over-year revenue increase can continue or translate into steady cash available.
Analyst inference
Adjusted earnings matched the average analyst expectation, while revenue exceeded its forecast, giving investors two different measures of performance. The article also reports a 38.7% share-price fall this quarter and a 25.6% gain year to date, but does not establish that the results caused either move.
Analyst inference
What to watch
- Future quarterly reports could show whether revenue growth and adjusted profitability continue; sustained results would make the latest improvement more persuasive to investors. Analyst inference
- Analysts’ average earnings estimate rose about 166.7% over three months, but one analyst lowered an estimate in the past 30 days; later revisions may show changing expectations. Confirmed
- The article reports a $12 median 12-month analyst price target against a last closing price of $5.25; changes in targets or company results may alter that comparison. Confirmed
Evidence
- Original source link unavailable